Clinical Trials in East Windsor, New Jersey
10 recruiting
Showing 1–10 of 10 trials
Recruiting
Phase 3
A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab on Background Topical Corticosteroids Therapy in Participants Aged 12 Years and Older With Moderate-to-severe AD Who Have Had an Inadequate Response to Prior Biologic Therapy or an Oral JAK Inhibitor
Dermatitis Atopic
Sanofi636 enrolled147 locationsNCT06241118
Recruiting
Phase 4
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
PsoriasisOverweight or Obesity
Eli Lilly and Company200 enrolled43 locationsNCT06857942
Recruiting
Phase 4
Bimekizumab in Plaque Psoriasis
Plaque Psoriasis
Icahn School of Medicine at Mount Sinai60 enrolled2 locationsNCT06336343
Recruiting
Phase 4
Upadacitinib for Prurigo Nodularis
Prurigo Nodularis
Psoriasis Treatment Center of Central New Jersey25 enrolled1 locationNCT06773403
Recruiting
Phase 4
Dupixent and Narrowband UVB for Atopic Dermatitis
Atopic Dermatitis
Psoriasis Treatment Center of Central New Jersey40 enrolled1 locationNCT05285839
Recruiting
Phase 4
Duobrii in Combination With Biologics
Psoriasis
Psoriasis Treatment Center of Central New Jersey25 enrolled1 locationNCT04119102
Recruiting
Phase 4
Taltz in Combination With Enstilar for Psoriasis
Psoriasis
Psoriasis Treatment Center of Central New Jersey25 enrolled1 locationNCT04372277
Recruiting
Phase 4
ILUMYA in Combination With HALOG Ointment 0.1% for Plaque Psoriasis.
Psoriasis
Psoriasis Treatment Center of Central New Jersey25 enrolled1 locationNCT04347473
Recruiting
Phase 4
Enstilar in Combination With Enbrel or Humira for Plaque Psoriasis
Psoriasis
Psoriasis Treatment Center of Central New Jersey30 enrolled1 locationNCT03827876
Recruiting
Not Applicable
An Open-Label, Pilot Study to Evaluate the Efficacy of Narrowband Ultraviolet-B Phototherapy Three Times Weekly for Twelve Weeks in Moderate-to-Severe Psoriasis Patients
Psoriasis
Psoriasis Treatment Center of Central New Jersey30 enrolled1 locationNCT03392337